Page last updated: 2024-11-12

alantrypinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

alantrypinone: a Penicillium alkaloid; a tricyclic pyrazinoquinazolinedione base bridged by a 3-methyleneoxindole substructure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID10666980
MeSH IDM0297475

Synonyms (6)

Synonym
212911-06-3
alantrypinone
(1'r,3r,12'r)-12'-methylspiro[1h-indole-3,16'-2,10,13-triazatetracyclo[10.2.2.02,11.04,9]hexadeca-4,6,8,10-tetraene]-2,3',14'-trione
(1's,3s,12's)-12'-methyl-3'h,15'h-spiro[indole-3,13'-[2,10,16]triazatetracyclo[10.2.2.02,11.04,9]hexadeca[4,6,8,10]tetraene]-2,3',15'(1h)-trione
DTXSID70891846
Q63392384

Research Excerpts

Overview

Alantrypinone is an insecticidal alkaloid that acts as a selective antagonist for housefly (vs rat) GABA receptors. It is considered to be a lead compound for the development of a safer insecticide.

ExcerptReferenceRelevance
"Alantrypinone is an insecticidal alkaloid that acts as a selective antagonist for housefly (vs rat) GABA receptors, and is considered to be a lead compound for the development of a safer insecticide."( Alantrypinone and its derivatives: synthesis and antagonist activity toward insect GABA receptors.
Alam, MS; Arisawa, M; Mitomi, M; Narusuye, K; Nishida, A; Ozoe, Y; Watanabe, T; Yamamoto, K, 2009
)
2.52
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]